cysteine has been researched along with Cerebral Pseudosclerosis in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (65.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carru, C; Deiana, L; Pinna, GA; Sotgia, S; Zinellu, A | 1 |
| WALSHE, JM | 1 |
| BAKER, RA; BOULDING, JE; FISTER, WP | 1 |
| OSBORN, SB; WALSHE, JM | 1 |
| KLIMAN, B; PETERSON, RE; SEVEN, MJ | 1 |
| CUMINGS, JN | 1 |
| HARTLEY, BS; WALSHE, JM | 1 |
| FRIMPTER, GW | 1 |
| DEHAEN, P | 1 |
| EBASHI, F; EBASHI, S; MOMOI, H; OKINAKA, S; SUGITA, H; TOYOKURA, Y; WATANABE, T | 1 |
| HAANEN, CA; JANSEN, AP; MAJOOR, CL; SEIGNETTE, WT | 1 |
| Cater, MA; La Fontaine, S; Mercer, JF | 1 |
| Aikath, D; Chattopadhyay, I; Das, SK; Gangopadhyay, PK; Gupta, A; Hashmi, MA; Ray, K | 1 |
| Cooper, MJ; Gilliam, CT; Kaplan, JH; Lutsenko, S; Petrukhin, K | 1 |
| Cox, DW; Forbes, JR | 1 |
| Imai, N; Ishihara, N; Miyata, K; Nozaki, H; Terayama, Y | 1 |
| Bartsch, R; Klein, D; Summer, KH | 1 |
| Blumberg, WE; Peisach, J | 1 |
| Aposhian, HV | 1 |
| Dörl, F; Faur, A; Păsculescu, G | 1 |
1 review(s) available for cysteine and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Penicillamine and analogous chelating agents.
Topics: Acetates; Amino Acid Oxidoreductases; Animals; Chelating Agents; Copper; Cysteine; D-Amino-Acid Oxidase; Female; Hepatolenticular Degeneration; Humans; Lethal Dose 50; Liver; Lyases; Mercury Poisoning; Penicillamine; Rats; Species Specificity; Stereoisomerism; Venoms | 1971 |
19 other study(ies) available for cysteine and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
D-penicillamine interferes with S-homocysteinylation and S-cysteinylation of LDL apolipoprotein B.
Topics: Apolipoproteins B; Cysteine; Hepatolenticular Degeneration; Homocysteine; Humans; Penicillamine; Sulfhydryl Compounds | 2011 |
Wilson's disease; new oral therapy.
Topics: Cysteine; Hepatolenticular Degeneration; Humans | 1956 |
The treatment of hepatolenticular degeneration with penicillamine; with report of two cases.
Topics: Cysteine; Hepatolenticular Degeneration; Humans; Penicillamine | 1958 |
Effects of penicillamine and dimercaprol on turnover of copper in patients with Wilson's disease.
Topics: Copper; Cysteine; Dimercaprol; Hepatolenticular Degeneration; Humans; Penicillamine | 1958 |
Clinical studies with penicillamine in hepatolenticular degeneration.
Topics: Biomedical Research; Cysteine; Hepatolenticular Degeneration; Penicillamine | 1959 |
The treatment of hepatolenticular degeneration.
Topics: Cysteine; Dimercaprol; Hepatolenticular Degeneration; Humans | 1959 |
PENICILLAMINE AND MIXED DISULPHIDE EXCRETION IN WILSON'S DISEASE.
Topics: Cysteine; Cystinuria; Disulfides; Hepatolenticular Degeneration; Humans; Penicillamine; Sulfides | 1963 |
CYSTINURIA: METABOLISM OF THE DISULFIDE OF CYSTEINE AND HOMOCYSTEINE.
Topics: Amino Acids; Chromatography; Cysteine; Cystinuria; Disulfides; Dogs; Hepatolenticular Degeneration; Homocysteine; Ion Exchange Resins; Kidney Diseases; Metabolic Diseases; Methionine; Proteins; Rats; Sulfonic Acids; Sulfur Isotopes | 1963 |
THERAPEUTIC RESEARCH IN REVIEW.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antihypertensive Agents; Chelating Agents; Clinical Laboratory Techniques; Cysteine; Diazepam; Dosage Forms; Drug Industry; Drug Therapy; Hepatolenticular Degeneration; Herpes Simplex; Humans; Hypnotics and Sedatives; Idoxuridine; Imidazoles; Measles Vaccine; Methyldopa; Monoamine Oxidase Inhibitors; Norethindrone; Parasympatholytics; Penicillins; Research; Therapeutic Human Experimentation; Tranquilizing Agents; Vincristine | 1964 |
CYSTEINE-STIMULATED SERUM CREATINE KINASE IN HEALTH AND DISEASE.
Topics: Adolescent; Central Nervous System Diseases; Child; Clinical Enzyme Tests; Creatine Kinase; Cysteine; Dermatomyositis; Hepatolenticular Degeneration; Humans; Infant; Infant, Newborn; Muscular Diseases; Muscular Dystrophies; Myositis; Myotonic Dystrophy; Research | 1964 |
[The effects of penicillamine and versenate in the treatment of Wilson's disease and lead poisoning].
Topics: Cysteine; Edetic Acid; Hepatolenticular Degeneration; Humans; Lead Poisoning; Penicillamine | 1959 |
Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson protein (ATP7B).
Topics: Adenosine Triphosphatases; Amino Acid Sequence; Binding Sites; Cation Transport Proteins; Copper; Copper-Transporting ATPases; Cysteine; DNA Primers; Glutamic Acid; Glycine; Hepatolenticular Degeneration; Humans; Models, Molecular; Oligopeptides; Polymerase Chain Reaction; Protein Conformation; Threonine | 2007 |
Subcortical white matter abnormalities related to drug resistance in Wilson disease.
Topics: Adenosine Triphosphatases; Antidotes; Brain; Cation Transport Proteins; Child; Copper-Transporting ATPases; Cysteine; Disease Progression; Drug Resistance; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Penicillamine | 2006 |
N-terminal domains of human copper-transporting adenosine triphosphatases (the Wilson's and Menkes disease proteins) bind copper selectively in vivo and in vitro with stoichiometry of one copper per metal-binding repeat.
Topics: Adenosine Triphosphatases; Binding Sites; Carrier Proteins; Cation Transport Proteins; Cells, Cultured; Copper; Copper-Transporting ATPases; Cysteine; Hepatolenticular Degeneration; Humans; Kinetics; Menkes Kinky Hair Syndrome; Models, Molecular; Peptide Fragments; Protein Structure, Secondary; Recombinant Fusion Proteins; Solubility | 1997 |
Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?
Topics: Adenosine Triphosphatases; Apoenzymes; Biological Transport; Carrier Proteins; Cation Transport Proteins; Cell Division; Ceruloplasmin; Copper; Copper Transport Proteins; Copper-Transporting ATPases; Cysteine; DNA, Complementary; Fungal Proteins; Genetic Complementation Test; Hepatolenticular Degeneration; Humans; Immune Sera; Iron; Mutagenesis, Site-Directed; Mutation, Missense; Phenotype; Recombinant Fusion Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Temperature | 1998 |
[Short interval change of 99mTc-ethyl cysteinate dimer single photon emission computed tomography in Wilson's disease].
Topics: Adolescent; Brain; Cysteine; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Organotechnetium Compounds; Penicillamine; Radiopharmaceuticals; Thalamus; Tomography, Emission-Computed, Single-Photon | 1999 |
Quantitation of Cu-containing metallothionein by a Cd-saturation method.
Topics: Animals; Cadmium; Cadmium Radioisotopes; Cells, Cultured; Chemistry Techniques, Analytical; Child; Child, Preschool; Chromatography, Gel; Copper; Cysteine; Ethanolamines; Fibroblasts; Glutathione; Hepatolenticular Degeneration; Humans; Male; Metallothionein; Molybdenum; Rats; Rats, Inbred Strains | 1990 |
A mechanism for the action of penicillamine in the treatment of Wilson's disease.
Topics: Chelating Agents; Copper; Cysteine; Edetic Acid; Electron Spin Resonance Spectroscopy; Hepatolenticular Degeneration; Methods; Models, Biological; Nitrogen; Penicillamine; Sulfur; Thiosemicarbazones | 1969 |
[Current treatment of hepatolenticular degenerescence].
Topics: Adrenal Cortex Hormones; Cysteine; Diet Therapy; Dimercaprol; Edetic Acid; Folic Acid; Hepatolenticular Degeneration; Humans; Penicillamine | 1972 |